References
- Andreasson, S., Allebeck, P., Engstrom, A., & Rydberg, U. (1987, December 26). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. The Lancet, 330(8574), 1483–1486. https://doi.org/https://doi.org/10.1016/S0140-6736(87)92620-1
- Anglin, D. M., Corcoran, C. M., Brown, A. S., Chen, H., Lighty, Q., Brook, J. S., & Cohen, P. R. (2012, May). Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood. Schizophrenia Research, 137(1–3), 45–49. https://doi.org/https://doi.org/10.1016/j.schres.2012.01.019
- Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002, November 23). Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ (Clinical Research ed.), 325(7374), 1212–1213. https://doi.org/https://doi.org/10.1136/bmj.325.7374.1212
- Ball, S. A. (2004). Personality traits, disorders and substance abuse. In R. M. Stelmack (Ed.), On the psychobiology of personality: Essays in honor of Marvin Zuckerman (pp. 203–222). Elsevier.
- Barkus, E., & Lewis, S. (2008, September). Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychological Medicine, 38(9), 1267–1276. https://doi.org/https://doi.org/10.1017/S0033291707002619
- Barkus, E. J., Stirling, J., Hopkins, R. S., & Lewis, S. (2006). Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology, 39(4), 175–178. https://doi.org/https://doi.org/10.1159/000092678
- Barrantes-Vidal, N., Grant, P., & Kwapil, T. R. (2015, March). The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders. Schizophrenia Bulletin, 41(Suppl 2), S408–S416. https://doi.org/https://doi.org/10.1093/schbul/sbu191
- Bolhuis, K., Kushner, S. A., Yalniz, S., Hillegers, M. H. J., Jaddoe, V. W. V., Tiemeier, H., & El Marroun, H. (2018, December). Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring. Schizophrenia Research, 202, 322–327. https://doi.org/https://doi.org/10.1016/j.schres.2018.06.067
- Boydell, J., Dean, K., Dutta, R., Giouroukou, E., Fearon, P., & Murray, R. (2007, July). A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: Implications for the concept of cannabis psychosis. Schizophrenia Research, 93(1–3), 203–210. https://doi.org/https://doi.org/10.1016/j.schres.2007.03.014
- Chong, H. Y., Teoh, S. L., Wu, D. B., Kotirum, S., Chiou, C. F., & Chaiyakunapruk, N. (2016). Global economic burden of schizophrenia: A systematic review. Neuropsychiatric Disease and Treatment, 12, 357–373.https://doi.org/https://doi.org/10.2147/NDT.S96649
- Cornelius, J. R., & Kirisci, L. (2013). Assessing TLI as a predictor of treatment seeking for SUD among youth transitioning to young adulthood. Advances in Psychology Research, 98, 85–94. https://www.ncbi.nlm.nih.gov/pubmed/25379028
- Cornelius, J. R., Kirisci, L., Reynolds, M., Vanyukov, M., & Tarter, R. (2015, May). Does the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood?The American Journal of Drug and Alcohol Abuse, 41(3), 264–268. https://doi.org/https://doi.org/10.3109/00952990.2015.1011744
- Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., Butt, A., Stilo, S. A., Wiffen, B., Powell, J., & Murray, R. M. (2009). Dec). High-potency cannabis and the risk of psychosis. The British Journal of Psychiatry : The Journal of Mental Science, 195(6), 488–491. https://doi.org/https://doi.org/10.1192/bjp.bp.109.064220
- Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., La Barbera, D., Tarricone, I., Berardi, D., Szoke, A., Arango, C., Tortelli, A., Velthorst, E., Bernardo, M., Del-Ben, C. M., … Group, E.-G W. (2019, May). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study. The Lancet Psychiatry, 6(5), 427–436. https://doi.org/https://doi.org/10.1016/S2215-0366(19)30048-3
- Dubertret, C., Bidard, I., Ades, J., & Gorwood, P. (2006, September). Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophrenia Research, 86(1–3), 284–290. https://doi.org/https://doi.org/10.1016/j.schres.2006.05.006
- Dumas, P., Saoud, M., Bouafia, S., Gutknecht, C., Ecochard, R., Dalery, J., Rochet, T., & d’Amato, T. (2002, January 31). Cannabis use correlates with schizotypal personality traits in healthy students. Psychiatry Research, 109(1), 27–35. https://doi.org/https://doi.org/10.1016/S0165-1781(01)00358-4
- Fergusson, D. M., Horwood, L. J., & Swain-Campbell, N. R. (2003, January). Cannabis dependence and psychotic symptoms in young people. Psychological Medicine, 33(1), 15–21. https://doi.org/https://doi.org/10.1017/S0033291702006402
- Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., Moller, M., Sartorius, N., & Woodruff, P. (2014, April). Schizophrenia-time to commit to policy change. Schizophrenia Bulletin, 40(Suppl 3), S165–S194. https://doi.org/https://doi.org/10.1093/schbul/sbu006
- Fontes, M. A., Bolla, K. I., Cunha, P. J., Almeida, P. P., Jungerman, F., Laranjeira, R. R., Bressan, R. A., & Lacerda, A. L. (2011, June). Cannabis use before age 15 and subsequent executive functioning. The British Journal of Psychiatry : The Journal of Mental Science, 198(6), 442–447. https://doi.org/https://doi.org/10.1192/bjp.bp.110.077479
- Freeman, D., Dunn, G., Murray, R. M., Evans, N., Lister, R., Antley, A., Slater, M., Godlewska, B., Cornish, R., Williams, J., Di Simplicio, M., Igoumenou, A., Brenneisen, R., Tunbridge, E. M., Harrison, P. J., Harmer, C. J., Cowen, P., & Morrison, P. D. (2015, March). How cannabis causes paranoia: Using the intravenous administration of Δ9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia . Schizophrenia Bulletin, 41(2), 391–399. https://doi.org/https://doi.org/10.1093/schbul/sbu098
- Gage, S. H., Hickman, M., & Zammit, S. (2016, April 1). Association between cannabis and psychosis: Epidemiologic evidence. Biological Psychiatry, 79(7), 549–556. https://doi.org/https://doi.org/10.1016/j.biopsych.2015.08.001
- Gage, S. H., Jones, H. J., Burgess, S., Bowden, J., Davey Smith, G., Zammit, S., & Munafo, M. R. (2017, April). Assessing causality in associations between cannabis use and schizophrenia risk: A two-sample Mendelian randomization study. Psychological Medicine, 47(5), 971–980. https://doi.org/https://doi.org/10.1017/S0033291716003172
- Gage, S. H., Zammit, S., & Hickman, M. (2013). Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. F1000 Medicine Reports, 5, 2. https://doi.org/https://doi.org/10.3410/M5-2
- Gillespie, N. A., Aggen, S. H., Neale, M. C., Knudsen, G. P., Krueger, R. F., South, S. C., Czajkowski, N., Nesvag, R., Ystrom, E., Kendler, K. S., & Reichborn-Kjennerud, T. (2018, August). Associations between personality disorders and cannabis use and cannabis use disorder: A population-based twin study. Addiction (Abingdon, England), 113(8), 1488–1498. https://doi.org/https://doi.org/10.1111/add.14209
- Goldstein, J. M., Buka, S. L., Seidman, L. J., & Tsuang, M. T. (2010, May). Specificity of familial transmission of schizophrenia psychosis spectrum and affective psychoses in the New England family study’s high-risk design. Archives of General Psychiatry, 67(5), 458–467. https://doi.org/https://doi.org/10.1001/archgenpsychiatry.2010.38
- Grant, P. (2015). Is schizotypy per se a suitable endophenotype of schizophrenia? - Do not forget to distinguish positive from negative facets. Front Psychiatry, 6, 143.https://doi.org/https://doi.org/10.3389/fpsyt.2015.00143
- Hammond, C. J., Chaney, A., Hendrickson, B., & Sharma, P. (2020, February 6). Cannabis use among U.S. adolescents in the era of marijuana legalization: A review of changing use patterns, comorbidity, and health correlates. International Review of Psychiatry, 32(3), 221-234. https://doi.org/https://doi.org/10.1080/09540261.2020.1713056
- Henquet, C., van Os, J., Kuepper, R., Delespaul, P., Smits, M., Campo, J. A., & Myin-Germeys, I. (2010, June). Psychosis reactivity to cannabis use in daily life: An experience sampling study. The British Journal of Psychiatry : The Journal of Mental Science, 196(6), 447–453. https://doi.org/https://doi.org/10.1192/bjp.bp.109.072249
- Howes, O. D., & Murray, R. M. (2014, May 10). Schizophrenia: An integrated sociodevelopmental-cognitive model. Lancet (London, England), 383(9929), 1677–1687. https://doi.org/https://doi.org/10.1016/S0140-6736(13)62036-X
- Johnson, R. M., & Guttmannova, K. (2019, February 1). Marijuana use among adolescents and emerging adults in the midst of policy change: Introduction to the special issue. Prevention Science : The Official Journal of the Society for Prevention Research, 20(2), 179–184. https://doi.org/https://doi.org/10.1007/s11121-019-0989-7
- Jones, A., Christiansen, P., Nederkoorn, C., Houben, K., & Field, M. (2013, October 22). Fluctuating disinhibition: Implications for the understanding and treatment of alcohol and other substance use disorders. Frontiers in Psychiatry, 4, 140. https://doi.org/https://doi.org/10.3389/fpsyt.2013.00140
- Kelly, E. M., Dodge, J. L., Sarkar, M., French, A. L., Tien, P. C., Glesby, M. J., Golub, E. T., Augenbraun, M., Plankey, M., & Peters, M. G. (2016, August 15). Marijuana use is not associated with progression to advanced liver fibrosis in HIV/hepatitis C virus-coinfected women. Clinical Infectious Diseases, 63(4), 512–518. https://doi.org/https://doi.org/10.1093/cid/ciw350
- Kirisci, L., Tarter, R., Mezzich, A., Ridenour, T., Reynolds, M., & Vanyukov, M. (2009, January–February). Prediction of cannabis use disorder between boyhood and young adulthood: Clarifying the phenotype and environtype. The American Journal on Addictions, 18(1), 36–47. https://doi.org/https://doi.org/10.1080/10550490802408829
- Leckman, J. F., Sholomskas, D., Thompson, W. D., Belanger, A., & Weissman, M. M. (1982, August). Best estimate of lifetime psychiatric diagnosis: A methodological study. Archives of General Psychiatry, 39(8), 879–883. https://doi.org/https://doi.org/10.1001/archpsyc.1982.04290080001001
- Lichtenstein, P., Yip, B. H., Bjork, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009, January 17). Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. The Lancet, 373(9659), 234–239. https://doi.org/https://doi.org/10.1016/S0140-6736(09)60072-6
- Manrique-Garcia, E., Zammit, S., Dalman, C., Hemmingsson, T., Andreasson, S., & Allebeck, P. (2012, June). Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychological Medicine, 42(6), 1321–1328. https://doi.org/https://doi.org/10.1017/S0033291711002078
- Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007, July 28). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet, 370(9584), 319–328. https://doi.org/https://doi.org/10.1016/S0140-6736(07)61162-3
- Power, R. A., Verweij, K. J., Zuhair, M., Montgomery, G. W., Henders, A. K., Heath, A. C., Madden, P. A., Medland, S. E., Wray, N. R., & Martin, N. G. (2014, November). Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular Psychiatry, 19(11), 1201–1204. https://doi.org/https://doi.org/10.1038/mp.2014.51
- Radhakrishnan, R., Wilkinson, S. T., & D’Souza, D. C. (2014). Gone to pot - A review of the association between cannabis and psychosis. Frontiers in Psychiatry, 5, 54. https://doi.org/https://doi.org/10.3389/fpsyt.2014.00054
- Raza, G. T., DeMarce, J. M., Lash, S. J., & Parker, J. D. (2014). Paranoid personality disorder in the United States: The role of race, illicit drug use, and income. Journal of Ethnicity in Substance Abuse, 13(3), 247–257. https://doi.org/https://doi.org/10.1080/15332640.2013.850463
- Ridenour, T. A., Kirisci, L., Tarter, R. E., & Vanyukov, M. M. (2011, December 1). Could a continuous measure of individual transmissible risk be useful in clinical assessment of substance use disorder? Findings from the National Epidemiological Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence, 119(1-2), 10–17. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2011.05.018
- Sami, M. B., & Bhattacharyya, S. (2018, August). Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders. Journal of Psychopharmacology (Oxford, England), 32(8), 825–849. https://doi.org/https://doi.org/10.1177/0269881118760662
- Schultze-Lutter, F., Nenadic, I., & Grant, P. (2019). Psychosis and schizophrenia-spectrum personality disorders require early detection on different symptom dimensions. Frontiers in Psychiatry, 10, 476https://doi.org/https://doi.org/10.3389/fpsyt.2019.00476
- Seddon, J. L., Birchwood, M., Copello, A., Everard, L., Jones, P. B., Fowler, D., Amos, T., Freemantle, N., Sharma, V., Marshall, M., & Singh, S. P. (2016, May). Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: A report from the UK national EDEN Study. Schizophrenia Bulletin, 42(3), 619–625. https://doi.org/https://doi.org/10.1093/schbul/sbv154
- Sevy, S., Robinson, D. G., Napolitano, B., Patel, R. C., Gunduz-Bruce, H., Miller, R., McCormack, J., Lorell, B. S., & Kane, J. (2010, July). Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophrenia Research, 120(1–3), 101–107. https://doi.org/https://doi.org/10.1016/j.schres.2010.03.037
- Spauwen, J., Krabbendam, L., Lieb, R., Wittchen, H. U., & van Os, J. (2004, November). Early maternal stress and health behaviours and offspring expression of psychosis in adolescence. Acta Psychiatrica Scandinavica, 110(5), 356–364. https://doi.org/https://doi.org/10.1111/j.1600-0447.2004.00429.x
- Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1992, August). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of General Psychiatry, 49(8), 624–629. https://doi.org/https://doi.org/10.1001/archpsyc.1992.01820080032005
- Spitzer, R. L., W. J., Gibbon, M., & First, M. B. (1990). User’s guide for the structured clinical interview for DSM-III-R: SCID. American Psychiatric Association.
- Stirling, J., Barkus, E. J., Nabosi, L., Irshad, S., Roemer, G., Schreudergoidheijt, B., & Lewis, S. (2008). Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort. Psychopathology, 41(6), 371–378. https://doi.org/https://doi.org/10.1159/000155215
- Tarter, R. E. (1990). Evaluation and treatment of adolescent substance abuse: A decision tree method. The American Journal of Drug and Alcohol Abuse, 16(1–2), 1–46. https://doi.org/https://doi.org/10.3109/00952999009001570
- Tarter, R. E., Kirisci, L., Mezzich, A., Cornelius, J. R., Pajer, K., Vanyukov, M., Gardner, W., Blackson, T., & Clark, D. (2003, June). Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. The American Journal of Psychiatry, 160(6), 1078–1085. https://doi.org/https://doi.org/10.1176/appi.ajp.160.6.1078
- Vanyukov, M. M., Kirisci, L., Moss, L., Tarter, R. E., Reynolds, M. D., Maher, B. S., Kirillova, G. P., Ridenour, T., & Clark, D. B. (2009, May). Measurement of the risk for substance use disorders: Phenotypic and genetic analysis of an index of common liability. Behavior Genetics, 39(3), 233–244. https://doi.org/https://doi.org/10.1007/s10519-009-9269-9
- Vanyukov, M. M., Kirisci, L., Tarter, R. E., Simkevitz, H. F., Kirillova, G. P., Maher, B. S., & Clark, D. B. (2003, October). Liability to substance use disorders: 2. A measurement approach. Neuroscience and Biobehavioral Reviews, 27(6), 517–526. https://doi.org/https://doi.org/10.1016/j.neubiorev.2003.08.003
- Vanyukov, M. M., Tarter, R. E., Kirisci, L., Kirillova, G. P., Maher, B. S., & Clark, D. B. (2003, October). Liability to substance use disorders: 1. Common mechanisms and manifestations. Neuroscience and Biobehavioral Reviews, 27(6), 507–515. https://doi.org/https://doi.org/10.1016/j.neubiorev.2003.08.002
- Wechsler, D. (1991). WISC-III: Wechsler intelligence scale for children. Psychological Corporation.
- White, I. R., Royston, P., & Wood, A. M. (2011, February 20). Multiple imputation using chained equations: Issues and guidance for practice. Statistics in Medicine, 30(4), 377–399. https://doi.org/https://doi.org/10.1002/sim.4067
- Wilkinson, S. T., Radhakrishnan, R., & D’Souza, D. C. (2014, June 1). Impact of cannabis use on the development of psychotic disorders. Current Addiction Reports, 1(2), 115–128. https://doi.org/https://doi.org/10.1007/s40429-014-0018-7
- Williams, J. B., Gibbon, M., First, M. B., Spitzer, R. L., Davies, M., Borus, J., Howes, M. J., Kane, J., Pope, H. G., Jr., & Rounsaville, B. (1992, August). The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Archives of General Psychiatry, 49(8), 630–636. https://doi.org/https://doi.org/10.1001/archpsyc.1992.01820080038006
- Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002, November 23). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. BMJ, 325(7374), 1199–1199. https://doi.org/https://doi.org/10.1136/bmj.325.7374.1199
- Zammit, S., & Lewis, G. (2004, October). Exploring the relationship between cannabis use and psychosis. Addiction (Abingdon, England), 99(10), 1353–1355.https://doi.org/https://doi.org/10.1111/j.1360-0443.2004.00843.x
- Zammit, S., Thomas, K., Thompson, A., Horwood, J., Menezes, P., Gunnell, D., Hollis, C., Wolke, D., Lewis, G., & Harrison, G. (2009, October). Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring. The British Journal of Psychiatry : The Journal of Mental Science, 195(4), 294–300. https://doi.org/https://doi.org/10.1192/bjp.bp.108.062471